A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

PHASE2CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Chronic Renal Failure

Interventions

DRUG

OPC-41061

DRUG

OPC-41061

DRUG

Placebo

Trial Locations (4)

Kanto

Kinki

Kyushu

Tōhoku